Search Login Register

Familial Dysalbuminemic Hyperthyroxinemia Summary

54 relevant articles (0 outcomes, 6 trials/studies) found for this Disease

Description: An inherited autosomal dominant trait characterized by abnormally elevated levels of total serum THYROXINE; (T4) in euthyroid patients with abnormal SERUM ALBUMIN that binds T4 with enhanced affinity. The serum levels of free T4, free T3, and TSH are normal. It is one of several T4 abnormalities produced by non-thyroid disorder. This condition is due to mutations of the ALB gene on CHROMOSOME 4.

Also Known As: Hyperthyroxinemia, Familial Dysalbuminemic; Dysalbuminemic Hyperthyroxinemia, Familial

Key Drugs and Agents for Familial Dysalbuminemic Hyperthyroxinemia

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Thyroxine (Levothyroxine) : 3 studies in 29 results : FDA 14 Generic
  2. Serum Albumin : 3 studies in 11 results : IBA
  3. Thyroxine-Binding Proteins (Thyroxine-Binding Globulin) : 2 studies in 4 results : IBA
  4. Triiodothyronine (Liothyronine) : 1 study in 3 results : FDA 1
  5. Thyroid Hormones : 1 study in 2 results : IBA
  6. Staphylococcal Protein A (A, Protein) : 1 study in 1 result : IBA
  7. Carrier Proteins (Binding Protein) : 5 results : IBA
  8. Prealbumin (Transthyretin) : 4 results : IBA
  9. Hormones : 4 results : IBA
  10. Thyrotropin (Thyroid-Stimulating Hormone) : 3 results : FDA 1
Show All >>

Diseases Related to Familial Dysalbuminemic Hyperthyroxinemia

  1. Syndrome
  2. Thyroid Diseases (Thyroid Disease)
  3. Hyperthyroxinemia
  4. Hyperthyroidism
  5. Thyroid Hormone Resistance Syndrome (Thyroid Hormone Resistance)
Show All >>

Key Therapies for Familial Dysalbuminemic Hyperthyroxinemia

Efficacy Chart >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2008 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.